These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 24038593)
1. Relation of clinical subtypes in Parkinson's disease with survival. de Lau LM; Verbaan D; van Rooden SM; Marinus J; van Hilten JJ Mov Disord; 2014 Jan; 29(1):150-1. PubMed ID: 24038593 [No Abstract] [Full Text] [Related]
2. Do autonomic function tests in people with Parkinson's disease predict survival rates at 7 years follow-up? Gray WK; Wood BH; Walker RW Mov Disord; 2009 Dec; 24(16):2432-4. PubMed ID: 19890986 [No Abstract] [Full Text] [Related]
3. [Clinical subtypes of Parkinson disease]. Poewe W; Gerstenbrand F Wien Med Wochenschr; 1986 Aug; 136(15-16):384-7. PubMed ID: 3788189 [TBL] [Abstract][Full Text] [Related]
4. Psychiatric complications and shift of death age in Parkinson's disease. Danielczyk W; Fischer P Adv Neurol; 1990; 53():405-10. PubMed ID: 2239481 [No Abstract] [Full Text] [Related]
5. [Clinical subtypes of Parkinson's disease]. Mizuno Y No To Shinkei; 1993 Feb; 45(2):105-12. PubMed ID: 8476659 [No Abstract] [Full Text] [Related]
6. Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study. Ben-Shlomo Y; Lees A; Neurology; 2001 Jul; 57(2):369; author reply 369-70. PubMed ID: 11480425 [No Abstract] [Full Text] [Related]
7. Longitudinal study of effects of early levodopa treatment on disability and mortality in Parkinson's disease. Diamond SG; Markham CH Adv Neurol; 1990; 53():399-403. PubMed ID: 2239480 [No Abstract] [Full Text] [Related]
8. Retrospective study of preventive effect of maize on mortality from Parkinson's disease in Japan. Fukushima T; Tanaka K; Ushijima K; Moriyama M Asia Pac J Clin Nutr; 2003; 12(4):447-50. PubMed ID: 14672869 [TBL] [Abstract][Full Text] [Related]
9. A controlled study of dementia in Parkinson's disease over 54 months. Mindham RH; Biggins CA; Boyd JL; Harrop FM; Madeley P; Randall JI; Spokes EG Adv Neurol; 1993; 60():470-4. PubMed ID: 8420172 [No Abstract] [Full Text] [Related]
10. The neuromythology of Parkinson's Disease. Calne DB; Mizuno Y Parkinsonism Relat Disord; 2004 Jul; 10(5):319-22. PubMed ID: 15196512 [TBL] [Abstract][Full Text] [Related]
14. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder? Lamberti P; de Mari M; Iliceto G; Federico F Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988 [TBL] [Abstract][Full Text] [Related]
15. Geographic distribution of deaths due to Parkinson's disease in Canada: 1979-1986. Svenson LW Mov Disord; 1990; 5(4):322-4. PubMed ID: 2259356 [TBL] [Abstract][Full Text] [Related]
17. Does levodopa therapy delay death in Parkinson's disease? Uitti RJ; Ahlskog JE; Maraganore DM Mov Disord; 1996 May; 11(3):343-4. PubMed ID: 8723162 [No Abstract] [Full Text] [Related]
18. Clinical subtypes of Parkinson's disease. van Rooden SM; Colas F; Martínez-Martín P; Visser M; Verbaan D; Marinus J; Chaudhuri RK; Kok JN; van Hilten JJ Mov Disord; 2011 Jan; 26(1):51-8. PubMed ID: 21322019 [TBL] [Abstract][Full Text] [Related]
19. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up). Duarte J; García Olmos LM; Mendoza A; Clavería LE Acta Neurol Scand; 2013 May; 127(5):295-300. PubMed ID: 22957805 [TBL] [Abstract][Full Text] [Related]